Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xin-Lu Pang
Over-Expressed microRNA-181a Reduces Glomerular Sclerosis and Renal Tubular Epithelial Injury in Rats With Chronic Kidney Disease via Down-Regulation of the TLR/NF-κB Pathway by Binding to CRY1
Molecular Medicine
Molecular Medicine
Genetics
Molecular Biology
Related publications
Effect of Bufei Yishen Granules Combined With Electroacupuncture in Rats With Chronic Obstructive Pulmonary Disease via the Regulation of TLR-4/NF-κB Signaling
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
MicroRNA‑146a Improves Sepsis‑induced Cardiomyopathy by Regulating the TLR‑4/NF‑κB Signaling Pathway
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Bradykinin Receptor in Immune-Mediated Renal Tubular Injury in Trichloroethylene-Sensitized Mice: Impact on NF-κB Signaling Pathway
Journal of Immunotoxicology
Toxicology
Immunology
Down-Regulation of MRPS23 Inhibits LPS-induced Proliferation and Invasion via Regulation of the NF-κB Signaling Pathway in Osteosarcoma Cells
RSC Advances
Chemistry
Chemical Engineering
Protective Effect of Hydroxysafflor Yellow a Against Acute Kidney Injury via the TLR4/NF-κB Signaling Pathway
Scientific Reports
Multidisciplinary
Down-Regulation of HMGB1 Expression by shRNA Constructs Inhibits the Bioactivity of Urothelial Carcinoma Cell Lines via the NF-κB Pathway
Scientific Reports
Multidisciplinary
ATG5-mediated Autophagy Suppresses NF-κB Signaling to Limit Epithelial Inflammatory Response to Kidney Injury
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Oroxylin-A Rescues LPS-Induced Acute Lung Injury via Regulation of NF-κB Signaling Pathway in Rodents
PLoS ONE
Multidisciplinary
Regulation of the Nuclear Factor (NF)-κB Pathway by ISGylation
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
